Human jejunal effective permeability and its correlation with preclinical drug absorption models

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 7, 1997, Pages 627-638

  Lennernäs, Hans ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; GLUCOSE; GLYCOPROTEIN P; LEUCINE; LEVODOPA; METOPROLOL; PHENAZONE;

BLOOD BRAIN BARRIER; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG ABSORPTION; DRUG PENETRATION; DRUG TRANSPORT; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; JEJUNUM; MATHEMATICAL ANALYSIS; MEMBRANE TRANSPORT; PHARMACOKINETICS; REVIEW; SMALL INTESTINE ABSORPTION;

EID: 0030797273     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06084.x     Document Type: Review

References (107)

1. Ahrenstedt, Ö., Knutson, L., Nilsson, B., Nilsson-Ekdahl, K., Odlind, B., Hällgren, R. (1990) Enhanced local production of complement components in the small intestines in Crohn's disease. N. Eng. J. Med. 322: 1345-1349
2. Amidon, G. L., Lennernäs, H., Shah, V. P., Crison, J. (1995) Theoretical considerations in the correlation of in vitro drug product dissolution and in vivo bioavailability: a basis for a biopharmaceutics drug classification. Pharm. Res. 12: 413-420
3. Artursson, P., Karlsson, J. (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 3: 880-885
4. Artursson, P., Ungell, A-L., Löfroth, J-E. (1993) Selective paracellular permeability in two models of intestinal absorption: Cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharm. Res. 10: 1123-1129
5. Belle, van K., Ebinger G., Michotte Y. (1994) Microdialysis for the quantitaive study of the distribution kinetics of the anti-epileptic drug, carbamazepine, to the brain. Proc. 6th Int. Conference on In Vivo Methods. Seignosse, France Sept. 17-20 1994
6. Benet L. Z., Wu, C-Y., Hebert, M. F., Wacher, V. J. (1996) The importance of drug metabolism and antitransport processes: A paradigm shift in oral drug delivery. J. Contr. Rel. 39: 139-143
7. Brasitus, H. A., Dudeja, P. K. (1985) Regional differences in the lipid composition and fluidity of rat colonic brush-border membranes. Biochim. Biophys. Acta 819: 10-17
8. Burton, P. S., Conradi, R. A., Hilgers, A. R., Ho, N. F. H. (1993) Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells. Biochem. Biophys. Res. Commun. 190: 760-766
9. Burton, P. S., Conradi, R. A., Ho, N. F. H., Hilgers, A. R., Borchardt, R. T. (1996) How structural features influence the biomembrane permeability of peptides. J. Pharm. Sci. 85: 1336-1340
10. Bönlökke, L., Christensen F. N., Knutson L., Kristensen H. G., Lennernäs H. (1997) A new approach for direct in vivo dissolution studies of low soluble drugs. Pharm. Res. in press
11. Chadwick, V. S., Phillips, S. F., Hofmann, A. F. (1977) Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology 73: 247-251
12. Chikhale, E. G., Ng K-Y., Burton, P. S., Borchardt, R. T. (1994) Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides. Pharm. Res. 11: 412-419
13. Conradi, R. A., Hilgers, A. R., Ho, N. F. H., Burton, P. S. (1992) The influence of peptide structure on transport across Caco-2 cells. II. Peptide bond modification which results in improved permeability. Pharm. Res. 9: 435-439
14. Cooper, E. R., Kasting, G. (1987) Transport across epithelial membranes. J. Contr. Rel. 6: 23-35
15. Croop, J. M., Raymond, M., Haber, D., Devault, A., Arceci, R. J., Gros, P., Houseman, D. (1989) The three multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal humans tissues. Mol. Cell Biol. 9: 1346-1350
16. Danhof, M., van Zuilen, A., Boeijinga, J. K., Breimer, D. D. (1982) Studies of different metabolic pathways of antipyrine in man. Eur. J. Clin. Pharmacol. 21: 433-441
17. Dehouck, M-P., Jolliet-Riant P., Bree, F., Fruchart J-C., Cecchelli, R., Tillement, J-P. (1992) Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models. J. Neurochem. 58: 1790-1797
18. De Waizers I. (1990) Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferase in rat and human hepatic and extrahepatic tissues. J. Pharmacol. Exp. Ther. 253: 387-394
19. Diamond, J. M. (1995) News and views: How to be physiological. Nature 376: 117-8
20. Dressman, J., Yamada, T. (1991) Animal models for drug absorption. In: Welling, P. G., Tse, F. L. S., Dighe, S. V. (eds) Pharmaceutical Bioequivalence, Marcel Dekker. p. 250.
21. Fagerholm, U., Lennernäs, H. (1995) Experimental estimation of the effective unstirred water layer thickness in the human jejunum, and its importance in oral drug absorption. Eur J. Pharm. Sci. 3: 247-253
22. Fagerholm, U., Borgström, L., Ahrenstedt, Ö., Lennernäs H. (1995) The lack of effect of induced net fluid absorption on the in vivo permeability of terbutaline in the human jejunum. J. Drug Targeting 3: 191-200
23. Fagerholm, U., Johansson, M., Lennernäs, H. (1996) The correlation between rat and human small intestinal permeability to drugs with different physico-chemical properties. Pharm. Res. 13: 1335-1341
24. Fine, K. D., Santa Ana, C. A., Porter, J. L., Fordtran, J. S. (1993) Effect of D-glucose on intestinal permeability and its passive absorption in human small intestine in vivo. Gastroenterology 105: 1117-1125
25. Fine, K. D., Santa Ana, C. A., Porter, J. L., Fordtran, J. S. (1994) Mechanism by which glucose stimulates the passive absorption of small solutes by the human jejunum in vivo. Gastroenterology 109: 1391-1396
26. Flynn, G. L., Yalkowsky, S. H., Roseman, T. J. (1974) Mass transport phenomena and models: theoretical concepts. J. Pharm. Sci. 63: 479-509
27. Ford, J. M., Hait, W. N. (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42: 155-199
28. Fricker, G., Drewe, J., Huwyle, J., Gutman, H., Beglinger, C. (1996) Relevance of P-glycoprotein for the enteral absorption of cyclosporin A: in vitro and in vivo correlation. Br. J. Pharmacol. 118: 1841-1847
29. Gisolfi, C. V., Summers, R. W., Schedl, P., Bleiler, T. L. (1992) Intestinal water absorption from select carbohydrate solutions in humans. J. Appl. Physiol. 73: 2142-2150
30. Gumbleton, M., Sneader, W. (1994) Pharmacokinetic considerations in rational drug design. Clin. Pharmacokin. 26: 161-168
31. Gramatté, T., Oertel, R., Terhaag, B., Kirch, W. (1996) Direct demonstration of small intestinal secretion and site-dependent absorption of the β-blocker talinolol in humans. Clin. Pharmacol. Ther. 59: 541-549
32. Ho, N. F. H., Park, J. Y., Ni, P. F., Higuchi W. I. (1983) Advancing quantitative and mechanistic approaches in interfacing gastrointestinal drug absorption studies in animals and humans. In: Crouthamel, W., Sarapu, A. C. (eds) Animal Models for Oral Drug Delivery in Man; In Situ and In Vivo Approaches. American Pharmaceutical Association, Washington D.C., pp 27-106
33. Hidalgo, I. J., Li, J. (1996) Carrier-mediated transport and efflux mechanisms in Caco-2 cells. Adv. Drug Del. Rev. 22: 53-66
34. Hirasawa, T., Muraoka, T., Karino, A., Hayashi, M., Awazu, S. (1984) Solvent drag in jejunal absorption of salicylic acid and antipyrine obtained by in situ single-pass perfusion method in rat. J. Pharmacobiodyn. 7: 246-253
35. Hollander, D., Koyama, S., Dadufalza, V., Tran, D. Q., Krugliak, P., Ma, T., Ling, K-Y. (1989) Polyethylene glycol 900 permeability of rat intestinal and colonic segments in vivo and brush border membrane vesicles in vitro. J. Lab. Clin. Med. 113: 505-515
36. Hu, M., Borchardt, R. T (1990). Mechanism of L-a-methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2). Pharm. Res. 7: 1313-1319
37. Hunt, J. B., Elliott, R. J., Farthing, M. J. G. (1991) Comparison of rat and human intestinal perfusion models for assessing efficacy of oral rehydration solutions. Aliment. Pharmacol. Ther. 5: 49-59
38. 2O absorption clearances. J. Pharm. Dyn. 5: 410-417
39. Knutson, L., Odlind, B., Hällgren, R. (1989) A new technique for segmental jejunal perfusion in man. Am. J. Gastroenterol. 84: 1278-1284
40. Knutson, L., Ahrenstedt, Ö. B., Odlind, B., Hällgren, R. (1990) The jejunal secretion of histamine is increased in active Crohn's disease. Gastroenterology 98: 849-854
41. Kolars, J .C., Awni, W. M., Merion, R. M., Watkins, P. B. (1991) First-pass metabolism of cyclosporin by the gut. Lancet 338: 1488-1490
42. Komiya, I., Park, J. Y., Kamani, A., Ho, N. F. H., Higuchi, W. I. (1980) Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes. Int. J. Pharmaceut. 4: 249-262
43. Lande, M. B., Priver, N. A., Zeidel, M. L (1994) Determinants of apical membrane permeabilities of barrier epithelia. Am. J. Physiol. 267: C367-C374
44. Lande, M. B., Donovan, J. M., Zeidel, M. L (1995) The relationship between membrane fluidity and permeabilities to water, solutes, ammonia, and protons. J. Gen. Physiol. 106: 67-84
45. Lennernäs, H., Ahrenstedt, Ö., Hällgren, R., Knutson, L., Ryde, M., Paalzow, L.K. (1992) Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man. Pharm. Res. 9: 1243-1251
46. Lennernäs, H., Nilsson, D., Aquilonius, S-M., Ahrenstedt, Ö., Knutson, L., Paalzow, L. K. (1993a) The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man. Br. J. Clin. Pharmacol. 35: 243-250
47. Lennernäs, H. (1994) Gastrointestinal absorption mechanisms: a comparison between animal and human models. Eur J. Pharm. Sci. 2: 39-43
48. Lennernäs, H. (1995) Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation? Pharm. Res. 12: 1573-82
49. Lennernäs, H., Regårdh, C. G. (1993) Dose-dependent intestinal absorption and significant intestinal excretion (exsorption) of the beta-blocker pafenolol in the rat. Pharm. Res. 5: 727-731
50. Lennernäs, H., Renberg, L., Hoffman, K-J., Regårdh, C. G. (1993) Presystemic elimination of pafenolol in the rat after oral and ip administration and identification of the main metabolite in both rats and humans. Drug Metabol. Disp. 21: 435-440
51. Lennernäs, H., Ahrenstedt, Ö., Ungell, A-L. (1994) Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat. Br. J. Clin. Pharmacol. 37: 589-596
52. Lennernäs, H., Knutson, L., Knutson, T., Lesko, L., Salmonson, T., Amidon, G. L. (1995a) Human effective permeability data for furosemide, hydrochlorthiazide, ketoprofen and naproxen to be used in the proposed biopharmaceutical classification for IR-products. Pharm. Res. 12: 396
53. Lennernäs, H., Knutson, L., Knutson, T., Lesko, L., Salmonson, T., Amidon, G. L. (1995b) Human effective permeabilitiy data for atenolol, metoprolol and carbamazepine to be used in the proposed biopharmaceutical classification for IR-products. Pharm. Res. 12: 295
54. Lennernäs, H., Crison, J., Amidon, G. L. (1995c) Permeability and clearance views of drug absorption: a commentary. J. Pharmacokin. Biopharm. 23: 333-337
55. Lennernäs, H., Fagerholm, U., Raab, Y., Gerdin, B., Hällgren, R. (1995d) Regional rectal perfusion, a new in vivo approach to study rectal drug absorption in man. Pharm. Res. 12: 426-432
56. Lennernäs, H., Palm, K., Fagerholm, U., Artursson, P. (1996a) Correlation between paracellular and transcellular drug permeability in the human jejunum and Caco-2 monolayers. Int. J. Pharm. 127: 103-107
57. eff-value for each enantiomer of (R,S)-verapamil. Pharm. Res. 13: S-246
58. Lennernäs, H., Knutson, L., Lesko, L., Salmonson, T., Amidon, G. L. (1996c) Human jejunal permeabilities comparison to a-methyldopa and L-dopa: two carrier mediated drugs. Pharm. Res. 13: S-329
59. Lennernäs, H., Lee, I-D, Fagerholm, U., Amidon, G. L. (1997a) A residence-time distribution analysis of the hydrodynamics within the intestine in man during a regional single-pass perfusion with Loc-I-Gut: in-vivo permeability estimation. J. Pharm. Pharmacol. 49: 682-686
60. Lennernäs, H., Nylander, S., Ungell, A-L. (1997b) Correlation of effective drug permeability measurements in vitro using the Ussing chamber and the human jejunal perfusion. Pharm. Res. 14: 667-671
61. Lien, E. J. (1970) Physicochemical properties and gastrointestinal absorption of drugs. Drug Intell. Clin. Pharmacol. 4: 7-9
62. Lien, E. J. (1974) The relationship between chemical structure and drug absorption, distribution and excretion. In: Maas, J. (ed.) Drug Medical Chemistry IV, Proceedings of the 4th Int. Symp. on Med. Chem. Amsterdam, pp 319-342
63. Lindahl, A., Sandström, R. Ungell, A-L., Abrahmsson, B., Knutson, L., Knutson, T., Lennernäs, H. (1996) Jejunal permeability and hepatic extraction of fluvastatin in humans. Clin. Pharmacol. Ther. 60: 493-503
64. Madara, J. L., Pappenheimer, J. R. (1987) Structural basis for physiological regulation of paracellular pathways in intestinal epithelia. J. Membr. Biol. 100: 149-164
65. Madara, J. L., Trier, J. S. (1994) The functional morphology of the mucosa of the small intestine. In: Johnson, L. R. (ed.) Physiology of the Gastrointestinal Tract, 3rd edn. Raven Press, New York
66. Merfeld, A. E., Mlodozeniec, A. R., Cortese, M. A., Rhodes, J. B., Dressman, J. B., Amidon, G. L. (1986) The effect of pH and concentration on alpha-methyldopa absorption in man. J. Pharm. Pharmacol. 38: 815-822
67. Martin, Y. C. (1981) A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry. J. Med. Chem. 24: 229-237
68. Modigliani, R., Bernier, J. J. (1971) Absorption of glucose, sodium, and water by the human jejunum studied by intestinal perfusion with a proximal occluding balloon and at a variable flow rates. Gut 12: 184-193
69. Nilsson, D., Fagerholm, U., Lennernäs, H. (1994) The influence of net water absorption on the permeability of antipyrine and levodopa in the human jejunum. Pharm. Res. 11: 1541-1545
70. Nerurkar, M. M., Burton, P. S., Borchardt, R. T. (1996) The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system. Pharm. Res. 13: 528-534
71. Ochsenfahrt, H., Winne, D. (1974) The contribution of solvent drag to the intestinal absorption of the basic drugs amidopyrine and antipyrine from the jejunum of the rat. Naunyn Schmiederbergs Arch. Pharmacol. 281: 175-196
72. Osiecka, I., Cortese, M., Porter, P. A., Borchardt, R. T., Fix, J. A., Gardner, C. R. (1987) Intestinal absorption of a-methyldopa: in vitro mechanistic studies in rat small intestinal segments. J. Pharmacol. Exp. Ther. 242: 443-449
73. Overton, E. (1899) Ueber die allgemeinen osmotischen Eigenschaften der Zelle, ihre vermutlichen Ursachen und ihre Bedeutung für die Physiologie. Vierteljahrsschr. Naturforsch. Ges. Zuerich. 44: 88-135
74. Palm, K., Luthman, K. Ungell, A-L. Strandlund, G., Artursson, P. (1996) Correlation of drug absorption with molecular surface properties. J. Pharm. Sci. 85: 32-39
75. Pappenheimer, J. R. (1987) Physiological regulation of transepithelial impedance in the intestinal mucosa of rats and hamsters. J. Membr. Biol. 100: 137-148
76. Pappenheimer, J. R. (1993) On the coupling of membrane digestion with intestinal absorption of sugars and amino acids. Am. J. Physiol. 265: G409-417
77. Pappenheimer, J. R., Reiss, K. Z. (1987) Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat. J. Membr. Biol. 100: 123-136
78. Pappenheimer, J. R., Dahl, C. E., Karnovsky, M. L., Maggio, J. E. (1994) Intestinal absorption and excretion of octapeptides composed of D amino acids. Proc. Natl Acad. Sci. 91: 1942-1945
79. Pardridge, W. M., Triguero, D., Yang, J., Cancilla, P. A. (1990) Comparison of in vitro and in vivo models of drug transcytosisi through the blood brain barrier. J. Pharmacol. Exp. Ther. 253: 884-891
80. Pardridge, W. M. (1995) Adv. Drug Delivery Res. 15: 1-3
81. Phillips, S. F., Summerskill, W. H. J. (1966) Occlusion of the jejunum for intestinal perfusion in man Mayo Clin. Proc. 41: 224-231
82. Powell, D. W. (1987) Intestinal water and electrolyte transport In: Johnson, J. L (ed.) Physiology of the Gastrointestinal Tract, Raven Press, New York, pp 1267-1306
83. 1-adrenoceptor antagonist with atypical absorption and disposition properties - in man. Pharm. Res. 7: 1222-1227
84. Sadowski, D. C., Meddings, J. B. (1993) Luminal nutrients alter tight-junction permeability in the rat jejunum: an in vivo perfusion model. Can. J. Physiol. Pharmacol. 71: 835-839
85. Samanen, J., Wilson, G., Smith, P. L., Lee, C-P., Bondinell, W., Ku, T., Rhodes, G., Nichols, A. (1996) Chemical approaches to improve the oral bioavailability of peptidergic molecules. J. Pharm. Pharmacol. 48: 119-125
86. Schwartz, R. M., Furne, J. K., Levitt, M. D (1995). Paracellular intestinal transport of six-carbon sugars is negligible in the rat. Gastroenterology 109: 1206-1213
87. See, N., Bass, P. (1993) Nutrient-induced changes in the permeability of the rat jejunal mucosa. J. Pharm. Sci. 82: 721-4
88. Sladen, G. E., Dawson, A. M: (1970) Further studies on the pertfusion method for measuring intestinal absorption in man: the effects of a proximal occlusive balloon and a mixing segment. Gut 11: 947-954
89. Smith, D. A., Jones, B. C., Walker, D. K. (1996) Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics. Med. Res. Rev. 16: 243-266
90. Stein, W. D. (1986) Transport and Diffusion Across Cell Membranes. Academic Press; London, pp 69-112
91. Sundquist, T., Magnusson, K-E., Spödahl, I., Tagesson, C. (1980) Passage of molecules through the wall of the gastrointestinal tract. Gut 21: 208-214
92. Taylor, D. C (1986). Sites and mechanisms of intestinal drug absorption. Pharm. Int. 6: 179-183
93. Taylor, D. C., Lynch, J., Leahy, D. E. (1990) In: Hardy, J. G., Davis S.S., Wilson, C.G. (eds) Drug Delivery to the Gastrointestinal Tract. Ellis Horwood Ltd, Chichester, pp 133-145
94. Testa, B., Carrupt, P-A., Gaillard, P., Billois, F., Weber, P. (1996) Lipophilicity in molecular modelling. Pharm. Res. 13: 335-343
95. Thiebaud, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., Willingham, M.C. (1987) Cellular localization of the multi-drug resistance gene product P-glycoprotein in normal human tissues. Proc. Natl Acad. Sci. 84: 7735-7738
96. Tsuji, A., Tamai, I. (1996) Carrier-mediated intestinal transport of drugs. Pharm. Res. 13: 963-977
97. Uhing, M. R., Kimura, R. E. (1995a ) The effect of surgical bowel manipulation and anaesthesia on intestinal glucose absorption in rats. J. Clin. Invest. 95: 2790-2798
98. Uhing, M. R., Kimura, R. E. (1995b) Active transport of 3-O-methyl-glucose by the small intestine in chronically catheterized rats. J. Clin. Invest. 95: 2799-2805
99. van de Waterbeemd, H., Kansy, M. (1992) Hydrogen-bonding capacity and brain penetration. Chimia 299-303
100. Van Bree, J. B. M. M., Baljet A.V., van Geyt A., de Boer A. G., Danhof M., Breimer D. D. (1989) The unit impulse response procedure for the pharmacokinetic evaluation of drug entry into central nervous system. J. Pharmacokin. Biopharm. 17: 441-462
101. Wang, S-X., Sutfin, T. A., Bäärnhilem, C., Regårdh, C. G. (1989) Contribution of the intestine to the first-pass metabolism of felodipine in the rat. J. Pharmacol. Exp. Ther. 250: 632-636
102. Waterbeemd, H., Camenisch, Folkers, G., Raevsky O. A. (1996) Estimation of Caco-2 cell permeability using calculated molecular descriptors. Quant. Struct. Act. Relat. 15: 480-490
103. Winne, D. (1974a) The contribution of solvent drag to the intestinal absorption of the basic drugs aminopyrine and antipyrine from the jejunum of the rat. Naunyn Schmiedebergs Arch. Pharmacol. 281: 175-196
104. Winne, D. (1974b) The contribution of solvent drag to the intestinal absorption of the acidic drugs benzoic acid and salicylic acid from the jejunum of the rat. Naunyn Schmiedebergs Arch. Pharmacol. 281: 197-217
105. Winne, D. (1984) Role of blood flow in intestinal permeation. In: T. Z. Csáky (ed.) Pharmacology of Intestinal Permeation II, Springer-Verlag, Berlin, pp 301-347
106. Woodcock, D. M., Linsenmeyer, M. E., Chojnowski, G., Kriegler, A. B., Nink, V., Webster, L. K., Sawyer, W. H. (1992) Reversal of multidrug resistance. Br. J. Cancer 66: 62-68
107. Wu, C. Y., Benet, L. Z., Hebert, M. F., Gupta, S. K., Rowland, M., Gomez, D. Y., Wacher, V. J. (1995) Differentiation of absorption, first-pass gut and hepatic metabolism in man: studies with cyclosporine. Clin. Pharmacol. Ther. 58: 492-497